Vollam, Sarah http://orcid.org/0000-0003-2835-6271
Gustafson, Owen
Young, J. Duncan
Attwood, Benjamin
Keating, Liza
Watkinson, Peter
Funding for this research was provided by:
Research for Patient Benefit Programme (PB-PG-0215-36149)
NIHR Oxford Biomedical Research Centre
Article History
Received: 20 August 2020
Accepted: 2 December 2020
First Online: 6 January 2021
Ethics approval and consent to participate
: Ethical approval was granted by Wales REC 4 (reference: 17/WA/0139). Surviving patients consented to their involvement in the study. Details of the approach are included in the published protocol [CitationRef removed]. Confidentiality Advisory Group support was sought to access the records of deceased patients (reference: 17/CAG/0063).
: Not applicable.
: Peter Watkinson co-developed the System for Electronic Notification and Documentation (SEND), for which Sensyne Health has purchased a sole licence. The company has a research agreement with the University of Oxford and royalty agreements with Oxford University Hospitals NHS Trust and the University of Oxford. Sensyne Health may in the future pay Peter Watkinson personal fees. Peter Watkinson was Chief Medical Officer for Sensyne Health.